急性肾损伤的全程管理  

Management throughout the whole course of acute kidney injury

作　　者：艾珍[1,2] 陈崴 AI Zhen;CHEN Wei(Department of Nephrology,the First Affiliated Hospital,Sun Yat-sen University,Guangzhou,Guangdong 510080,P.R.China;NHC Key Laboratory of Clinical Nephrology(Sun Yat-sen University)and Guangdong Provincial Key Laboratory of Nephrology,Guangzhou,Guangdong 510080,P.R.China)

机构地区：[1]中山大学附属第一医院肾内科,广州510080 [2]国家卫生健康委员会肾脏病临床研究重点实验室(中山大学),广东省肾脏病重点实验室,广州510080

出　　处：《华西医学》2022年第7期1070-1075,共6页West China Medical Journal

基　　金：国家自然科学基金(82170737);广东省科学技术厅科技计划项目(2020B1212060028)。

摘　　要：急性肾损伤(acute kidney injury,AKI)的高发病率及高死亡率给全球卫生健康带来巨大挑战。近年前,中国在AKI流行病学、风险因素以及治疗方法上均取得了一些成果,但进一步的预防和诊治仍面临难题。该文结合目前的新观点和研究进展,汇总并解析了AKI的全程管理策略:AKI风险评估、早期预防、早期识别、治疗以及随访。目的是使中国肾病专科医生明确AKI的防治重点,规范AKI的管理,探寻适合中国AKI的防治诊疗规范。The high incidence and mortality of acute kidney injury(AKI)have brought great challenges to global health.In recent years,China has made some achievements in the epidemiology,risk factors and treatment of AKI.However,further prevention and treatment are still facing difficulties.Based on current new ideas and research progress,this paper summarized and analyzed the management throughout the whole course of AKI,including AKI risk assessment,early prevention,early identification,treatment and follow-up.The aim is to make Chinese nephrologists realize the focus of AKI prevention and treatment,standardize the management of AKI,and explore the prevention and treatment strategy suitable for AKI in China.

关 键 词：急性肾损伤 风险因素 生物标志物 预防 治疗 

分 类 号：R692[医药卫生—泌尿科学]